drugset / Trial / NCT03015831

Effect of Low Dose ColchiciNe on the InciDence of POAF

NCT03015831

Phase 3 Terminated 254 enrolled Jordan Collaborating Cardiology Group
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The prior End-AF study by the same group showed that 1 mg of colchicine didn't decrease the incidence of AF after cardiac surgery. The current study, End-AF Low Dose Study, will test 0.5 mg colchicine vs. placebo in preventing AF after cardiac surgery.

Timeline

Start
2017-10-02
Primary completion
2019-04-01
Completion
2019-05-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Colchicine Small molecule 0.5 mg Oral